Skip to main content
Clinical Trials/NCT01788241
NCT01788241
Active, not recruiting
Not Applicable

A Psycho-biochemical Perspective on Non-significant Coronary Artery Disease: a Prospective Cohort Study of Classic and Novel Risk Markers.

Tilburg University1 site in 1 country547 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Tilburg University
Enrollment
547
Locations
1
Primary Endpoint
Major Adverse Cardiac Events (MACE)
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

Psychosocial factors have been found to be associated with an increased risk for coronary artery disease incidence, progression and worse clinical outcomes.

Patients with non-significant coronary artery disease (confirmed vascular irregularities, but <60% coronary occlusion) often present with complaints such as chest pain, which warrant screening by coronary angiography (CAG) or computed tomography (CT scan). The prognosis of this group of patients with mild stenosis remains to be investigated in more detail, and we propose that psychosocial factors play a role in the clinical prognosis and patient reported outcomes in this group.

A special focus lies within examining personality characteristics, of which Type D personality is a primary predictor variable for prognosis. Type D personality is characterised by high negative affect and high social inhibition. In addition to psychosocial factors (personality, mood state, social support, SES), biomarkers(inflammation, clotting, DNA) as well as standard clinical risk factors (metabolic syndrome, activity level, smoking, medication use, disease severity) will be investigated.

The goal of the proposed study is to investigate a preexisting psycho-biochemical risk profile for major adverse cardiovascular events (MACE) and patient perceived symptoms in a group with angiographically or CT-scan confirmed, non-significant coronary artery disease.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
April 2025
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tilburg University
Responsible Party
Principal Investigator
Principal Investigator

Paula M.C. Mommersteeg

Assistant Professor

Tilburg University

Eligibility Criteria

Inclusion Criteria

  • Based on quantitative coronary angiography (CAG): visible, but non-significant (\<60% coronary occlusion) vascular irregularities and mild coronary stenosis.
  • Based on 64-slice CT-scan (CT-scan): detected non-significant stenosis (calcium score \>= lowest 10th percentile), and not eligible for CAG.

Exclusion Criteria

  • Normal coronary arteries (based on CAG or CT scan)
  • Significant occlusion of coronary arteries (\>=60% stenosis)
  • Eligible for coronary intervention such as PCI or CABG
  • History of coronary events (being either MI,PCI, CABG, heart failure)
  • For the CT-screened group: eligible for CAG based on the CT-scan
  • Serious comorbid conditions such as chronic kidney failure, or receiving chemotherapy
  • Insufficient knowledge of the Dutch language

Outcomes

Primary Outcomes

Major Adverse Cardiac Events (MACE)

Time Frame: Average 42 months (Range 12-72; at least 12 months after inclusion final participant)

MACE includes the occurence of a recurrent coronary angiography, emergency hospitalization (for cardiac reasons), myocardial infarction, percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG), mortality (cardiac/noncardiac)

Patient Perceived Health Status

Time Frame: 12 and 24 months

patient perceived health status includes self-reported chest pain, disease specific health status, generic health status, fatigue and mood (depression/anxiety). Double time point was included for this outcome measure to examine changes over time, compared to baseline.

Secondary Outcomes

  • Psychosocial factors(baseline, 12 and 24 months)
  • Biochemical correlates(baseline, 12 and 24 months)

Study Sites (1)

Loading locations...

Similar Trials